Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medterra Daily Relief CBD Oil Tincture is a consumer wellness product containing 99%+ pure isolated cannabidiol (CBD) derived from hemp. Developed by Medterra, the product is formulated with organic medium-chain triglyceride (MCT) oil as a carrier and is guaranteed to be THC-free. It is intended for oral or sublingual administration to support the endocannabinoid system, aiming to provide daily relief from discomfort, reduce stress, promote relaxation, and improve sleep quality. As a dietary supplement rather than a pharmaceutical drug, it is marketed for general wellness and a balanced lifestyle, interacting with the body's endocannabinoid receptors to maintain homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Medterra Daily Relief CBD Oil Tincture.